Previous 10 | Next 10 |
Neuronetics (STIM) has priced its public offering of 4.84M common shares at $15.50/share, for expected gross proceeds of ~$75M.Underwriters' over-allotment is an additional 726K shares. Net proceeds will be used for general corporate purposes, including working capital and R&D activities....
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric dis...
Gainers: [[NVAX]] +20.9%. [[SWKS]] +14.8%. [[WDC]] +10.2%. [[SCPS]] +8.9%. [[BBBY]] +8.5%.Losers: [[GSIT]] -20.8%. [[SNDE]] -17.9%. [[STIM]] -4.9%. [[FIZZ]] -4.2%. [[CRTX]] -3.7%. For further details see: NVAX, WDC, GSIT and FIZZ among after-hours movers
Neuronetics (STIM) dropped 3.7% in after hours after commencing an underwritten public offering; underwriters granted 30-day option to purchase an additional 15% of the shares.Offer size, actual terms have not been disclsoed.Net proceeds to be used for general corporate purposes, in...
MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric dis...
Gainers: VYNE Therapeutics (VYNE) +33%, Evolus (EOLS) +33%, Accelerate Diagnostics (AXDX) +32%, Atossa Therapeutics (ATOS) +29%, Bionano Genomics (BNGO) +27%.Losers: Neuronetics (STIM) -14%, Akerna (KERN) -10%, Precigen (PGEN) -9%,...
Do You Have These Top Health Care Stocks On Your Watchlist? In the stock market today , health care stocks are in the limelight. For one thing, it is a part of the stock market which investors flock to in good times and bad. This is because we will always require health care as ...
MALVERN, Pa., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its Ne...
Gainers: [[MTRX]] +24.8%. [[FARM]] +19.1%. [[STIM]] +15.9%. [[EXFO]] +13.1%. [[FSI]] +11.1%.Losers: [[PRTY]] -12.3%. [[QLI]] -9.2%. [[URBN]] -7.8%. [[PRVB]] -7.4%. [[AFMD]] -5.6%. For further details see: MTRX, FARM, PRTY and QLI among after-hours movers
Neuronetics (STIM) reports preliminary results ahead of its ICR presentation on Jan. 14. Q4 Revenue: To be in the range of $15-$15.5M, above the company's guidance range of $13-$13.5M, and vs. consensus of $13.24M. However, the preliminary revenue figures reflect a decline of ~14% and 11...
News, Short Squeeze, Breakout and More Instantly...
MALVERN, Pa., May 15, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders announced today that Humana has become the fir...
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite falling around 0.2% on Tuesday. The Dow traded up 0.01% to 38,857.00 ...
Shares of Beyond, Inc. (NYSE:BYON) fell sharply during Tuesday’s session following weaker-than-expected quarterly results. Beyond posted adj...